422 related articles for article (PubMed ID: 15936825)
1. Risk factors and outcome for nosocomial breakthrough candidaemia.
Pasqualotto AC; Nedel WL; Machado TS; Severo LC
J Infect; 2006 Mar; 52(3):216-22. PubMed ID: 15936825
[TBL] [Abstract][Full Text] [Related]
2. Nosocomial candidaemia in children: results of a 9-year study.
Celebi S; Hacimustafaoglu M; Ozdemir O; Ozkaya G
Mycoses; 2008 May; 51(3):248-57. PubMed ID: 18399906
[TBL] [Abstract][Full Text] [Related]
3. Neonatal candidaemia in Kuwait: a 12-year study of risk factors, species spectrum and antifungal susceptibility.
Al-Sweih N; Khan Z; Khan S; Devarajan LV
Mycoses; 2009 Nov; 52(6):518-23. PubMed ID: 18983425
[TBL] [Abstract][Full Text] [Related]
4. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.
Bassetti M; Ansaldi F; Nicolini L; Malfatto E; Molinari MP; Mussap M; Rebesco B; Bobbio Pallavicini F; Icardi G; Viscoli C
J Antimicrob Chemother; 2009 Sep; 64(3):625-9. PubMed ID: 19622536
[TBL] [Abstract][Full Text] [Related]
5. Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.
Chen SC; Marriott D; Playford EG; Nguyen Q; Ellis D; Meyer W; Sorrell TC; Slavin M;
Clin Microbiol Infect; 2009 Jul; 15(7):662-9. PubMed ID: 19614718
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality.
Weinberger M; Leibovici L; Perez S; Samra Z; Ostfeld I; Levi I; Bash E; Turner D; Goldschmied-Reouven A; Regev-Yochay G; Pitlik SD; Keller N
J Hosp Infect; 2005 Oct; 61(2):146-54. PubMed ID: 16009456
[TBL] [Abstract][Full Text] [Related]
7. Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.
Slavin MA; Sorrell TC; Marriott D; Thursky KA; Nguyen Q; Ellis DH; Morrissey CO; Chen SC;
J Antimicrob Chemother; 2010 May; 65(5):1042-51. PubMed ID: 20202987
[TBL] [Abstract][Full Text] [Related]
8. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
9. Candidaemia in an Irish tertiary referral hospital: epidemiology and prognostic factors.
Boo TW; O'reilly B; O'leary J; Cryan B
Mycoses; 2005 Jul; 48(4):251-9. PubMed ID: 15982207
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of risk factors and outcome among outpatient-acquired and nosocomial candidaemia.
Pasqualotto AC; Nedel WL; Machado TS; Severo LC
J Hosp Infect; 2005 Jun; 60(2):129-34. PubMed ID: 15866011
[TBL] [Abstract][Full Text] [Related]
11. Candida glabrata fungaemia in intensive care units.
Ruan SY; Lee LN; Jerng JS; Yu CJ; Hsueh PR
Clin Microbiol Infect; 2008 Feb; 14(2):136-40. PubMed ID: 18042196
[TBL] [Abstract][Full Text] [Related]
12. Secular trends in nosocomial candidaemia in non-neutropenic patients in an Italian tertiary hospital.
Luzzati R; Allegranzi B; Antozzi L; Masala L; Pegoraro E; Azzini A; Concia E
Clin Microbiol Infect; 2005 Nov; 11(11):908-13. PubMed ID: 16216107
[TBL] [Abstract][Full Text] [Related]
13. Nosocomial bloodstream infections associated with Candida species in a Turkish University Hospital.
Yapar N; Uysal U; Yucesoy M; Cakir N; Yuce A
Mycoses; 2006 Mar; 49(2):134-8. PubMed ID: 16466448
[TBL] [Abstract][Full Text] [Related]
14. Candidaemia in a large teaching hospital: a clinical audit.
Aliyu SH; Enoch DA; Abubakar II; Ali R; Carmichael AJ; Farrington M; Lever AM
QJM; 2006 Oct; 99(10):655-63. PubMed ID: 16935923
[TBL] [Abstract][Full Text] [Related]
15. [Epidemiological features of Candida infections detected in intensive care units and risk factors affecting mortality].
Acar A; Oncül O; Küçükardali Y; Ozyurt M; Haznedaroğlu T; Cavuşlu S
Mikrobiyol Bul; 2008 Jul; 42(3):451-61. PubMed ID: 18822889
[TBL] [Abstract][Full Text] [Related]
16. Effect of fluconazole consumption on long-term trends in candidal ecology.
Blot S; Janssens R; Claeys G; Hoste E; Buyle F; De Waele JJ; Peleman R; Vogelaers D; Vandewoude K
J Antimicrob Chemother; 2006 Aug; 58(2):474-7. PubMed ID: 16757503
[TBL] [Abstract][Full Text] [Related]
17. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the possible association between nosocomial candiduria and candidaemia.
Binelli CA; Moretti ML; Assis RS; Sauaia N; Menezes PR; Ribeiro E; Geiger DC; Mikami Y; Miyaji M; Oliveira MS; Barone AA; Levin AS
Clin Microbiol Infect; 2006 Jun; 12(6):538-43. PubMed ID: 16700702
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
[TBL] [Abstract][Full Text] [Related]
20. Candida glabrata fungemia: experience in a tertiary care center.
Malani A; Hmoud J; Chiu L; Carver PL; Bielaczyc A; Kauffman CA
Clin Infect Dis; 2005 Oct; 41(7):975-81. PubMed ID: 16142662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]